Ligand Pharmaceuticals Incorporated LGND
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Leland Gershell | Oppenheimer | 165.76 $ | 190 $ | 24.24 % | 03/09/2025 |
| Joseph Pantginis | H.C. Wainwright | 108.31 $ | 157 $ | 48.69 % | 21/10/2024 |
| Leland Gershell | Oppenheimer | 99.95 $ | 135 $ | 35.05 % | 02/10/2024 |
| Douglas Miehm | RBC Capital | 108.75 $ | 130 $ | 21.25 % | 30/07/2024 |
| Matt Hewitt | Craig-Hallum | 86.88 $ | 140 $ | 53.12 % | 09/07/2024 |
| Joseph Pantginis | H.C. Wainwright | 82.33 $ | 144 $ | 61.67 % | 28/06/2024 |